Details of the Drug Reposition

General Information of This Drug (ID: DMUSLW3)

Drug Name
Carbetocin   DMUSLW3
Synonyms
Carbetocino [INN-Spanish]; Carbetocinum [INN-Latin]; Duratocin (TN); 1-Buttersaeure-2-(3-(4-methoxyphenyl)-L-alanin)oxytocin; 1-{[(3r,6s,9s,12s,15s)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-[(2s)-butan-2-yl]-15-(4-hydroxybenzyl)-16-methyl-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosan-3-yl]carbonyl}-l-prolyl-l-leucylglycinamide
Therapeutic Class
Antitocolytic Agents
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Postpartum haemorrhage DISHIAJE JA43 Approved [1]
------------------------------------------------------------------------------------
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Prader-Willi syndrome DISYWMLU LD90.3 Withdrawn [2]
------------------------------------------------------------------------------------

References

1 Clinical Textbook of Dental Hygiene and Therapy. 2006, P237. By Robert Ireland.
2 Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease